EP3762015
GUSELKUMAB TIL NOTKUNAR VIÐ MEÐFERÐ Á CROHNS SJÚKDÓMI MEÐ SKAMMTAÁÆTLUN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.3.2019EP published:
24.12.2025EP application number:
19764856.1
EP translation filed:
13.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
3.3.2039Expiry date:
3.3.2027Next due date:
31.3.2027
Title in English:
GUSELKUMAB FOR USE IN THE TREATMENT OF CROHN'S DISEASE WITH A DOSAGE REGIMENLanguage of the patent:
English
Timeline
Today
4.3.2019EP application
24.12.2025EP Publication
13.3.2026Translation submitted
8.4.2026Registration published
3.3.2027Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Inventor
Name:
CHAN, DaphneAddress:
Spring House, Pennsylvania 19477, US
Name:
ADEDOKUN, OmoniyiAddress:
Spring House, Pennsylvania 19477, US
Name:
CHEN, YangAddress:
Spring House, Pennsylvania 19477, US
Name:
SZAPARY, PhilippeAddress:
Spring House, Pennsylvania 19477, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201862638624 PDate:
5.3.2018Country:
US
Classification
Categories:
A61K 38/17, A61K 39/395, A61P 1/00, C07K 14/54, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 5.3.2026
Expires: 3.3.2027
Payer: Árnason Faktor ehf.